The Claim
Thyroid-stimulating receptor antibodies (TRAb) may be detectable in patients with long-standing Hashimoto’s thyroiditis who subsequently develop hyperthyroidism, indicating a potential transition in the autoimmune response from destructive to stimulatory targeting of the TSH receptor.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In some people with long-term Hashimoto’s thyroiditis who later develop hyperthyroidism, antibodies that activate the TSH receptor can be found, suggesting a change in the type of immune response directed at this receptor.
See the scientific wording
Thyroid-stimulating receptor antibodies (TRAb) may be detectable in patients with long-standing Hashimoto’s thyroiditis who later develop hyperthyroidism, suggesting a potential shift in the autoimmune response targeting the TSH receptor from destructive to stimulatory activity.
What the research says
1 studyStudy: Autoimmune Switch of Hashimoto’s thyroiditis to Graves’ Disease: A Rare Case Report
Sometimes, people with Hashimoto’s thyroiditis—usually a condition that makes the thyroid slow down—can suddenly develop symptoms of an overactive thyroid because their immune system starts attacking the thyroid in a new way, producing antibodies that make it produce too much hormone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.